ITMCTR2200006534
Not yet recruiting
Phase 3
Clinical evidence-based evaluation of Traditional Chinese Medicine for prevention and treatment of diabetic high-risk foot
Hospital of Chengdu University of TCM0 sitesTBD
ConditionsHigh risk foot of diabetes
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- High risk foot of diabetes
- Sponsor
- Hospital of Chengdu University of TCM
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Meet the diagnostic criteria for type 2 diabetes defined in the Guideline for the prevention and treatment of type diabetes mellitus in China (2020 edition);
- •2\.Meet the diagnostic criteria for high\-risk foot for diabetes;
- •3\.Age between 18 and 80 years old, regardless of gender;
- •4\.Voluntarily participate in this trial and sign the informed consent.
Exclusion Criteria
- •1\. Patients with typical diabetic foot symptoms such as foot ulcers, infections, and gangrene;
- •2\.There are other diseases that cause damage to peripheral nerves and blood vessels;
- •3\.Mentally ill patients;
- •4\.Combined with serious heart, brain, kidney and other complications, or combined with other serious primary diseases;
- •5\.Those who have a history of allergies or allergies to drugs, food, pollen, etc.;
- •6\.Pregnant, lactating women and women planning to become pregnant;
- •7\.Those who use hormones and undergo surgical treatment and other stressful states of the body;
- •8\.Patients with acute diabetic complications such as ketoacidosis and hyperosmolarity and concurrent infections;
- •9\.Patients who use antioxidant drugs (such as lipoic acid), anti\-platelet aggregation drugs (such as aspirin enteric\-coated tablets), Chinese patent medicines and other nerve and vascular disease prevention drugs and nutritional nerve preparations (such as methylcobalamin);
- •10\.Those who have participated in other clinical trials within three months.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
A randomized controlled trial for Zhongfeng Xingnaoyie decoction in the treatment of Acute Cerebral InfarctioCerebral InfarctionITMCTR2100004506Hospital of Chengdu University of Traditional Chinese Medicine
Recruiting
Phase 1
Clinical observation and evaluation of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western MedicineITMCTR2000003113Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western Medicine
Recruiting
Not Applicable
Study on the therapeutic efficacy of conventional crude drug products 'Panaparl tablets' comprising of angelica root, cnidium rhizome, peony root, rehmannia root, etc. on cognitive impairmentMild cognitive impairment and early Alzheimer's diseaseJPRN-UMIN000028701Arimatsu Medical and Dental Clinic50
Recruiting
Phase 1
Clinical observation on the efficacy of traditional Chinese medicine colonic dialysis in the treatment of chronic kidney disease in stage 3-4ITMCTR2100004624onghua Hospital affiliated to Shanghai University of traditional Chinese Medicine
Recruiting
Phase 1
Clinical observation on the effect of traditional Chinese medicine hot-wet compression combined with salt moxibustion in cerebral apoplexy patients with gastric tube feedingITMCTR2000003044The Traditional Chinese Medicine Department of Tianjin Huanhu Hospital